Notice of Allowance helps establish the potential for use of the R and S isomers of Synthetic Nicotine in future nicotine replacement and smoking cessation products

SAN DIEGO, Aug. 25, 2019 /PRNewswire-PRWeb/ — Next Generation Labs, the sole manufacturer of TFN® nicotine, the world’s only bulk Synthetic Nicotine not made from, or derived from tobacco, has received a Notice of Allowance from the US Patent and Trade Mark Office (USPTO) in US 2017-0189388 for methods of treating nicotine addiction using a Synthetic Nicotine protocol.

The patent application, titled “Nicotine replacement therapy products comprising Synthetic Nicotine,” specifically claims a method for administration of a first ratio of synthetic R and S nicotine, and a subsequent administration of a second and different ratio of synthetic R and S nicotine. The Synthetic Nicotine used in the administrations includes a “nicotine product comprising a synthetic nicotine substantially free of one or more of nicotine-1?-N-oxide, nicotyrine, nornicotyrine, cotinine, 2?,3-bipyridyl, anabasine, N-methyl anatabine, N-methyl anabasine, anabasine, and/or anatabine.” The composition further includes one or more pharmaceutically acceptable excipients, additives and/or carriers.

Next Generation Labs is pleased this patent application has been allowed, as it helps establish the potential for use of the R and S isomers of Synthetic Nicotine in future nicotine replacement and smoking cessation products. R and S Synthetic Nicotine technology could become a significant component product ingredient in all smoking cessation products, as it finally gives the global pharmaceutical industry a viable alternative to the tobacco-derived nicotine that is currently used in all nicotine replacement products sold worldwide.

Given anticipated interest in the use of R-S nicotine in cessation products, Next Generation Labs will be offering its R-S, S and R nicotine products to companies in the pharmaceutical industry, under the brand name PharmaNic®.

We specialize in manufacturing chemical Synthetic Nicotine ( CAS No.: 54-11-5 ) in China. we have the highest technology and stable quality control , our factory has sophisticated technology production route to produce the above products ,welcome to inquiry it .Please contact us by e-mail nicotine@haihengpharma.com for quotation requests. Please provide quantity, purity, and any other specific requirements.

Synthetic NicotineSynthetic Nicotine is used for Medical and Drug
Notice of Allowance helps establish the potential for use of the R and S isomers of Synthetic Nicotine in future nicotine replacement and smoking cessation products SAN DIEGO, Aug. 25, 2019 /PRNewswire-PRWeb/ -- Next Generation Labs, the sole manufacturer of TFN® nicotine, the world's only bulk Synthetic Nicotine not made...